Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about CCI approves Ranbaxy acquisition by Sun Pharma
Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd announced on 9th December that they have received the order of the Competition Commission of India (“CCI”) dated December 5, 2014(“Order”) by which CCI has approved the acquisition of Ranbaxy by Sun Pharma, subject to compliance with certain conditions.
- Read more about Early-stage clinical trials of Ebola and Marburg vaccines are proved safe
Results of an early-stage clinical trial of two experimental vaccines against Ebola and Marburg viruses—the first to be completed in an African country—showed that they were safe and induced immune responses in healthy Ugandan adult volunteers.

[adsense:336x280:8701650588]
- Read more about Zerbaxa, new antibacterial drug got FDA approval
The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI).
- Read more about Ibuprofen could add years in your life
Ibuprofen, a common over-the-counter drug used to relieve pain and fever, could hold the keys to a longer healthier life, according to a study by researchers at the Buck Institute for Research on Aging. Publishing in PLoS Genetics on December 18th, scientists showed that regular doses of ibuprofen extended the lifespan of yeast, worms and fruit flies.
- Read more about Action taken by CDSCO against misuse and unethical stem cell clinical trial malpractices at hospital
Central Drugs Standard Control Organization (CDSCO) investigated a Pune based hospital after receiving compliant against hospital that they are performing unethical stem cell clinical trial and patients are highly charged for unapproved and illegal transplants.
- Read more about USFDA allows marketing of the first newborn screening test to help detect Severe Combined Immunodeficiency
The U.S. Food and Drug Administration today allowed marketing of the EnLite Neonatal TREC Kit, the first screening test permitted to be marketed by FDA for Severe Combined Immunodeficiency (SCID) in newborns.
- Read more about Scientists recognise Malaria parasites drug resistant
In two new studies, international research teams including NIAID scientists describe how certain genetic mutations make malaria-causing parasites resistant to artemisinin, a key drug for treating the disease. The findings are published in the Dec. 11, 2014, online issue of Science.
- Read more about Ministry of Health and Family Welfare strengthening Drug Regulatory System in India
Department of Health and Family Welfare proposes to implement a Central Sector Scheme for Strengthening the Central Drugs Standard Control Organisation (CDSCO); and State Drug Regulatory System during the residual period of Twelfth Five Year Plan (2012 - 2017) at an estimated cost of Rs.900 crore and Rs.850 crore (excluding States’ share) respectively.
- Read more about Tata Capital’s ‘India4India’ Survey Identifies Basic Healthcare and Illiteracy as the Top Challenges That India is Facing
(Business Wire India); Tata Capital, the financial services arm of the Tata Group, as part of its Do Right initiative, concluded a first-of-its-kind Survey to identify the major challenges facing our country today. The “Tata Capital India4India” Survey was conducted online on the website – doright.in & saw voting from more than 5000 respondents across the country. The top five challenges that emerged as the most concerning for the Indian public were Basic Healthcare, Illiteracy, Child Rights, Women Empowerment and Food Scarcity.
- Read more about Addendum 2015 of the Indian Pharmacopoeia 2014 is published
IP Addendum-2015 to IP-2014 has been released on 28.11.2014 by Sh. Lov Verma, Secretary Health & Family Welfare and Chairman, India Pharmacopoeia Commission in the presence of senior officers of Ministry of Health & Family Welfare and Scientific Staff of IP Commission.